We are live on ! Find out more
PCM

Parsons Capital Management Portfolio holdings

AUM $2.21B
1-Year Est. Return 28.12%
This Fund
S&P 500
This Quarter Est. Return
+3.38%
1 Year Est. Return
+28.12%
3 Year Est. Return
+84.89%
5 Year Est. Return
+106.02%
10 Year Est. Return
+395.61%
AUM
$735M
AUM Growth
+$4.25M
Cap. Flow
-$15.2M
Cap. Flow %
-2.07%
Top 10 Hldgs %
29.34%
Holding
337
New
11
Increased
111
Reduced
149
Closed
18

Top Buys

Rank Stock Value
1
FSTX
F-star Therapeutics, Inc. Common Stock
FSTX
+$1.2M
2
SLB icon
SLB Ltd
SLB
+$1.05M
3
MINT icon
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
+$851K
4
SYF icon
Synchrony
SYF
+$745K
5
VGT icon
Vanguard Information Technology ETF
VGT
+$663K

Top Sells

Rank Stock Value
1
BRK.A icon
Berkshire Hathaway Class A
BRK.A
+$12.7M
2
MMM icon
3M
MMM
+$1.65M
3
VEA icon
Vanguard FTSE Developed Markets ETF
VEA
+$756K
4
DLTR icon
Dollar Tree
DLTR
+$740K
5
HEDJ icon
WisdomTree Europe Hedged Equity Fund
HEDJ
+$694K

Sector Composition

Rank Sector Weight
1 Industrials 14.93%
2 Healthcare 14.57%
3 Technology 13.26%
4 Financials 9.86%
5 Energy 9.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DHR icon
26
Danaher
DHR
$138B
$6.13M 0.83%
90,337
-1,605
-2% -$105K
MRK icon
27
Merck
MRK
$321B
$5.99M 0.82%
109,021
-1,571
-1% -$83.6K
IVV icon
28
iShares Core S&P 500 ETF
IVV
$872B
$5.95M 0.81%
28,285
+1,428
+5% +$298K
MDXG icon
29
MiMedx Group
MDXG
$636M
$5.8M 0.79%
727,250
+2,550
+0.4% +$19.8K
TMO icon
30
Thermo Fisher Scientific
TMO
$214B
$5.66M 0.77%
38,299
-65
-0.2% -$9.59K
GOOGL icon
31
Alphabet (Google) Class A
GOOGL
$4.08T
$5.58M 0.76%
158,780
+7,420
+5% +$272K
BLK icon
32
Blackrock
BLK
$170B
$5.3M 0.72%
15,479
+120
+0.8% +$42.2K
MDLZ icon
33
Mondelez International
MDLZ
$80.5B
$5.28M 0.72%
115,971
-2,465
-2% -$107K
VCSH icon
34
Vanguard Short-Term Corporate Bond ETF
VCSH
$44.8B
$5.26M 0.72%
65,055
-298
-0.5% -$23.9K
VCIT icon
35
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
$66.3B
$5.24M 0.71%
58,551
+929
+2% +$81.5K
T icon
36
AT&T
T
$159B
$5.2M 0.71%
159,428
+3,741
+2% +$111K
CELG
37
DELISTED
Celgene Corp
CELG
$5.02M 0.68%
50,915
+1,475
+3% +$153K
ABT icon
38
Abbott
ABT
$183B
$5.02M 0.68%
127,642
+53
+0% +$2.11K
ABBV icon
39
AbbVie
ABBV
$455B
$4.96M 0.67%
80,029
-1,855
-2% -$113K
BMY icon
40
Bristol-Myers Squibb
BMY
$132B
$4.73M 0.64%
64,302
-2,945
-4% -$208K
COP icon
41
ConocoPhillips
COP
$145B
$4.55M 0.62%
104,271
+5,596
+6% +$247K
RTX icon
42
RTX Corp
RTX
$289B
$4.43M 0.6%
68,686
-556
-0.8% -$35.6K
NKE icon
43
Nike
NKE
$62.7B
$4.37M 0.59%
79,076
-1,855
-2% -$106K
PFF icon
44
iShares Preferred and Income Securities ETF
PFF
$13.3B
$4.08M 0.56%
102,397
-4,719
-4% -$185K
VO icon
45
Vanguard Morningstar Mid-Cap ETF
VO
$106B
$3.74M 0.51%
121,084
+2,920
+2% +$89.2K
WFC icon
46
Wells Fargo
WFC
$258B
$3.73M 0.51%
78,699
+1,199
+2% +$58.5K
MDT icon
47
Medtronic
MDT
$110B
$3.71M 0.5%
42,714
-415
-1% -$33.6K
VEA icon
48
Vanguard FTSE Developed Markets ETF
VEA
$230B
$3.45M 0.47%
97,452
-20,930
-18% -$756K
IMCB icon
49
iShares Morningstar Mid-Cap ETF
IMCB
$1.66B
$3.39M 0.46%
90,900
-1,840
-2% -$67.7K
VWO icon
50
Vanguard FTSE Emerging Markets ETF
VWO
$119B
$3.34M 0.45%
94,904
+15,120
+19% +$517K
1
2
3 4 5

Similar funds

BOI
Bank of Italy Rome, Italy $2.21B AUM 9.01% 1-Year Est. Return
WCMNY
Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return
NLGIA
Nippon Life Global Investors Americas New York $2.22B AUM 30.05% 1-Year Est. Return
ML
McAdam LLC Philadelphia, Pennsylvania $2.22B AUM 16.98% 1-Year Est. Return
IFA
Index Fund Advisors Irvine, California $2.22B AUM 20.66% 1-Year Est. Return
DPCM
Darlington Partners Capital Management Greenbrae, California $2.23B AUM 16.2% 1-Year Est. Return
RAM
Readystate Asset Management Chicago, Illinois $2.23B AUM 15% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return

Parsons Capital Management's Q2 2016 Portfolio in Review

As of Q2 2016, Parsons Capital Management held 337 positions worth $735M, up 0.58% from $731M the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Parsons Capital Management's Q2 2016 filing shows 11 new, 111 increased, 149 reduced and 18 closed positions. Its largest new stake was F-star Therapeutics, Inc. Common Stock: 27,953 shares worth $1.06M. The largest sale was Berkshire Hathaway Class A, an estimated $12.7M.

By sector, the portfolio is most concentrated in Industrials at 15% of assets, up from 15% a quarter earlier, followed by Healthcare and Technology.

  • Parsons Capital Management's largest Q2 2016 buy was F-star Therapeutics, Inc. Common Stock: 27,953 shares worth $1.06M.
  • Parsons Capital Management added most to SLB Ltd in Q2 2016, an estimated $1.05M increase.
  • Parsons Capital Management's biggest Q2 2016 reduction was Berkshire Hathaway Class A, cutting an estimated $12.7M.
  • Parsons Capital Management fully exited Vanguard FTSE Pacific ETF in Q2 2016, selling an estimated $619K.
  • Parsons Capital Management's ten largest holdings make up 29% of its $735M portfolio in Q2 2016.
  • Parsons Capital Management opened 11 new positions and closed 18 in Q2 2016.
  • Parsons Capital Management's portfolio value rose 0.58% quarter-over-quarter to $735M.

Based on Parsons Capital Management's 13F filing for Q2 2016, filed 10 Aug 2016.